Cutimed^® Siltec^® Sorbact^® B Sacrum

is a bacteria and fungi binding wound dressing, based on Sorbact^® Technology, designed for the sacral area. It consists of a Sorbact^® DACC™-coated wound contact layer, combined with an absorbent polyurethane foam that contains superabsorbent stripes and a border with silicone adhesive.

Prevents and treats wound infection
Safe removal of bacteria, fungi and endotoxins
Effective against most common resistant pathogens

Intended Purpose

Cutimed Siltec Sorbact B Sacrum is intended for use in the management of clean, contaminated, colonised or infected low to high exuding wounds, such as surgical wounds, traumatic wounds, pressure ulcers, diabetic foot ulcers and leg ulcers. It is intended to be used on superficial wounds.

Wear time: Should the clinical condition allow, the dressing can be left in place for up to 7 days.

Product benefits

Symbol of a shield representing infection prevention

Prevents and treats wound infection

Sorbact Technology dressings reduce bioburden and support effective wound healing, with no known contraindications and low risk of allergies^{1, 2, 3, 4, 5, 6}.

Symbol of looped threads to visualize that the product inhibits the growth of bacteria.

Safe removal of bacteria, fungi and endotoxins

Sorbact Technology dressings irreversibly bind and remove bacteria, without the release of active agents to the wound⁵. Development of bacterial or fungal resistance is not expected.

Effective against most common resistant pathogens

In vitro tests show that Sorbact Technology dressings are able to inhibit the growth of the Top 5 World Health Organization (WHO) pathogens ⁷.

Anatomical shape

Designed to fit the sacral area and provide good conformability, with silicone adhesive border that minimises trauma to the surrounding skin.

Waterproof and breathable backing film

The film provides protection against external contamination and allows excess fluid to evaporate.

Product facts

Superficial

Infected

Low to high

How to use

Image showing how to apply Cutimed® Siltec® Sorbact® Sacrum

1. Prepare the wound and surrounding skin according to local clinical practice. Ensure that the surrounding skin is clean and dry.
2. Select an appropriate dressing size and shape that covers the wound and is suitable for the anatomical location. The wound pad should overlap the wound margins. (A) Do not cut the dressing.
3. Remove the dressing from the peel pouch using an aseptic technique.
4. Remove the protective film (B) from the dressing and apply the dressing to the wound. Ensure that the Sorbact wound contact layer comes into direct contact with the complete wound surface to allow microorganisms to bind to the dressing.(C)
5. Avoid stretching the dressing.
6. The dressing change frequency depends on exudate levels and the overall condition of the wound and surrounding skin. Should the clinical condition allow, the dressing can be left in place for up to 7 days.
How to Remove
Gently remove Cutimed Siltec Sorbact B Sacrum from the wound and discard.

For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s Instructions for Use (IFU).

Product specifications

Product	Essity Product Code	Size	Pack Quantity
Cutimed^® Siltec^® Sorbact^® B Sacrum	7325148	17.5 cm x 17.5 cm	5
Cutimed^® Siltec^® Sorbact^® B Sacrum	7325149	23 cm x 23 cm	5

Medical References

¹ Bua N et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017;44:387-392.

² Stanirowski P et al. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt). 2016;17:427-435.

³ Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18.

⁴ Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127.

⁵ Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.

⁶ Gentili V et al. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact. Eur J Clin Microbiol Infect Dis. 2012;31:1523-1529.

⁷ Husmark J et al. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA. November 18-19, 2020, virtual conference (EP006).